These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15679168)

  • 21. Future of toxicology--low-dose toxicology and risk--benefit analysis.
    Rietjens IM; Alink GM
    Chem Res Toxicol; 2006 Aug; 19(8):977-81. PubMed ID: 16918235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In silico predictions of blood-brain barrier penetration: considerations to "keep in mind".
    Goodwin JT; Clark DE
    J Pharmacol Exp Ther; 2005 Nov; 315(2):477-83. PubMed ID: 15919767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In silico prediction of drug solubility in water-dioxane mixtures using the Jouyban-Acree model.
    Jouyban A
    Pharmazie; 2007 Jan; 62(1):46-50. PubMed ID: 17294813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In silico prediction of clinical efficacy.
    Michelson S; Sehgal A; Friedrich C
    Curr Opin Biotechnol; 2006 Dec; 17(6):666-70. PubMed ID: 17046236
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Applications of biotechnology to pharmacology and toxicology.
    Guillouzo A
    Cell Mol Biol (Noisy-le-grand); 2001 Dec; 47(8):1301-8. PubMed ID: 11838950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical relevance of preclinical testing for allergic side effects.
    Bala S; Weaver J; Hastings KL
    Toxicology; 2005 Apr; 209(2):195-200. PubMed ID: 15767036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute toxicity of alcohols: prediction by QSAR analysis and by molecular similarity.
    Rucki M; Tichý M
    Cent Eur J Public Health; 1997 Dec; 5(4):183-7. PubMed ID: 9457417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New QSPR study for the prediction of aqueous solubility of drug-like compounds.
    Duchowicz PR; Talevi A; Bruno-Blanch LE; Castro EA
    Bioorg Med Chem; 2008 Sep; 16(17):7944-55. PubMed ID: 18701302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction of rodent carcinogenic potential of naturally occurring chemicals in the human diet using high-throughput QSAR predictive modeling.
    Valerio LG; Arvidson KB; Chanderbhan RF; Contrera JF
    Toxicol Appl Pharmacol; 2007 Jul; 222(1):1-16. PubMed ID: 17482223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical validation of the "in silico" prediction of immunogenicity of a human recombinant therapeutic protein.
    Koren E; De Groot AS; Jawa V; Beck KD; Boone T; Rivera D; Li L; Mytych D; Koscec M; Weeraratne D; Swanson S; Martin W
    Clin Immunol; 2007 Jul; 124(1):26-32. PubMed ID: 17490912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does human pharmacokinetic prediction add significant value to compound selection in drug discovery research?
    Beaumont K; Smith DA
    Curr Opin Drug Discov Devel; 2009 Jan; 12(1):61-71. PubMed ID: 19152214
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Can we estimate the accuracy of ADME-Tox predictions?
    Tetko IV; Bruneau P; Mewes HW; Rohrer DC; Poda GI
    Drug Discov Today; 2006 Aug; 11(15-16):700-7. PubMed ID: 16846797
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Passive oral drug absorption can be predicted more reliably by experimental than computational models--fact or myth.
    Linnankoski J; Ranta VP; Yliperttula M; Urtti A
    Eur J Pharm Sci; 2008 Jul; 34(2-3):129-39. PubMed ID: 18455374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Keynote review: in vitro safety pharmacology profiling: an essential tool for successful drug development.
    Whitebread S; Hamon J; Bojanic D; Urban L
    Drug Discov Today; 2005 Nov; 10(21):1421-33. PubMed ID: 16243262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Computational toxicology in drug development.
    Muster W; Breidenbach A; Fischer H; Kirchner S; Müller L; Pähler A
    Drug Discov Today; 2008 Apr; 13(7-8):303-10. PubMed ID: 18405842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physiologically based pharmacokinetics (PBPK).
    Espié P; Tytgat D; Sargentini-Maier ML; Poggesi I; Watelet JB
    Drug Metab Rev; 2009; 41(3):391-407. PubMed ID: 19601719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction and classification of drug toxicity using probabilistic modeling of temporal metabolic data: the consortium on metabonomic toxicology screening approach.
    Ebbels TM; Keun HC; Beckonert OP; Bollard ME; Lindon JC; Holmes E; Nicholson JK
    J Proteome Res; 2007 Nov; 6(11):4407-22. PubMed ID: 17915905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predicting human liver microsomal stability with machine learning techniques.
    Sakiyama Y; Yuki H; Moriya T; Hattori K; Suzuki M; Shimada K; Honma T
    J Mol Graph Model; 2008 Feb; 26(6):907-15. PubMed ID: 17683964
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hormesis [biological effects of low-level exposure (B.E.L.L.E.)] and dermatology.
    Thong HY; Maibach HI
    Cutan Ocul Toxicol; 2007; 26(4):329-41. PubMed ID: 18058307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.